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Abstract
Defects in stress response are main determinants of cellular senescence and organ-
ism aging. In fibroblasts from patients affected by Hutchinson–Gilford progeria, a
severe LMNA‐linked syndrome associated with bone resorption, cardiovascular disor-
ders, and premature aging, we found altered modulation of CDKN1A, encoding p21,
upon oxidative stress induction, and accumulation of senescence markers during
stress recovery. In this context, we unraveled a dynamic interaction of lamin A/C
with HDAC2, an histone deacetylase that regulates CDKN1A expression. In control
skin fibroblasts, lamin A/C is part of a protein complex including HDAC2 and its his-
tone substrates; protein interaction is reduced at the onset of DNA damage
response and recovered after completion of DNA repair. This interplay parallels
modulation of p21 expression and global histone acetylation, and it is disrupted by
LMNA mutations leading to progeroid phenotypes. In fact, HGPS cells show impaired
lamin A/C‐HDAC2 interplay and accumulation of p21 upon stress recovery. Collec-
tively, these results link altered physical interaction between lamin A/C and HDAC2
to cellular and organism aging. The lamin A/C‐HDAC2 complex may be a novel ther-
apeutic target to slow down progression of progeria symptoms.
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1 | INTRODUCTION
Several evidences link lamin A/C to stress response. Prelamin A, the
precursor of lamin A, is transiently accumulated during oxidative or
replicative stress (Lattanzi et al., 2014; Liu, Drozdov, Shroff, Beltran,
& Shanahan, 2013). Moreover, proteins involved in repair of stress‐
induced DNA damage are recruited by lamins to damaged sites or
inside the nuclear compartment (Gibbs‐Seymour, Markiewicz, Bek-
ker‐Jensen, Mailand, & Hutchison, 2015; Gonzalez‐Suarez et al.,
2011; Lattanzi et al., 2014). Consistent with these functions, lamin
A/C has been implicated in mechanisms related to physiological (Lat-
tanzi et al., 2014) and pathological aging (Evangelisti, Cenni, & Lat-
tanzi, 2016), above all in progeroid laminopathies (Camozzi et al.,
2014). Here, we analyzed cells from patients affected by HGPS, a
premature aging syndrome linked to LMNA mutations, and observed
an altered modulation of CDKN1A, encoding p21, in HGPS under
oxidative stress. p21, alternatively p21WAF1/Cip1, is a cyclin‐depen-
dent kinase inhibitor that targets CDK2 and CDK1 complexes and
regulates cell cycle progression at G1/S border (Cazzalini, Scovassi,
Savio, Stivala, & Prosperi, 2010). Moreover, p21 has been shown to
play a role in the maintenance of G2‐phase arrest and to be the prin-
cipal mediator of cell cycle blockade in response to DNA damage
(Bell & Sharpless, 2007; Prives & Gottifredi, 2008). In fact, persistent
upregulation of p21 is associated with geroconversion (Bell & Sharp-
less, 2007; Karimian, Ahmadi, & Yousefi, 2016; Leontieva, Demi-
denko, & Blagosklonny, 2015). Previous studies had shown that
lamin A/C depletion is a trigger of p21 expression (Moiseeva, Bour-
deau, Vernier, Dabauvalle, & Ferbeyre, 2011). Moreover, accumula-
tion of toxic levels of prelamin A or progerin, the mutated prelamin
A form found in HGPS, was associated with upregulation of p53 tar-
get genes, including CDKN1A (Kudlow, Stanfel, Burtner, Johnston, &
Kennedy, 2008; Varela et al., 2005). However, the molecular link
between lamin A/C and p21 modulation remained elusive. Thus, hav-
ing observed altered p21 regulation upon oxidative stress in HGPS,
we set out to identify which molecule could mediate lamin A/C
effects on p21 expression. It has been demonstrated that histone
deacetylase 2 (HDAC2) is involved in the regulation of CDKN1A
gene. It was demonstrated (Peng et al., 2015) that HDAC2 is
recruited to CDKN1A promoter by FOXO3a and regulates p21
expression in cerebellar granule neuron. Furthermore, HDAC2 has
been shown to suppress p21 expression in human hepatocellular
carcinoma via its binding to an Sp1‐binding site (Noh et al., 2011).
On the other hand, it has been demonstrated that lamin A/C estab-
lishes direct interactions with histone deacetylases including SIRT1
(Cenni et al., 2014; Liu et al., 2012), SIRT6 (Ghosh, Liu, Wang, Hao,
& Zhou, 2015), and HDAC1 (Kubben et al., 2016), while lamin part-
ners at the nuclear envelope such as emerin, BAF, and LAP2beta
interact with HDAC3 (Demmerle, Koch, & Holaska, 2013) or HDAC2
(Tsai et al., 2015). Moreover, lamin A/C has been demonstrated to
bind gene promoters or neighboring domains and this binding has
been linked to distinct transcriptional outcomes (Lee, Welton, Smith,
& Kennedy, 2009; Lund & Collas, 2013; Mattout et al., 2011).
Finally, a clear link has been established between stress‐induced
chromatin remodeling, including acetylation or methylation of
HDAC2 substrates H3 histone lysine 9 (H3K9) and H4 histone lysine
16 (H4K16), and lamin A/C posttranslational modifications (Ghosh
et al., 2015; Lattanzi et al., 2007, 2014 ; Liu et al., 2013; Mattioli
et al., 2008). Based on the whole evaluation of those reported data,
we wondered if HDAC2 could mediate lamin A/C‐dependent effects
on p21 expression during DDR. Our data show that lamin A/C,
which binds CDKN1A promoter, interacts with HDAC2 to promote
deacetylase activity, and the interaction is reduced at the onset of
DDR and recovered after completion of DNA repair. This interplay
occurring during oxidative stress response parallels modulation of
p21 expression and global histone acetylation, all mechanisms dis-
rupted by LMNA mutations leading to progeroid phenotypes.
2 | RESULTS
2.1 | Altered regulation of p21 expression during
oxidative stress response in HGPS
It has been demonstrated that HGPS fibroblasts start acquiring a
senescent phenotype at late passages (Columbaro et al., 2005; Gold-
man et al., 2004; Meaburn et al., 2007). We hypothesized that an
altered response to stress stimuli could be a major determinant of cel-
lular aging in those cells. To test this hypothesis, we induced oxidative
stress in HGPS fibroblasts and age‐ and passage‐matched controls
(Table 1) and analyzed samples under basal conditions, during DNA
damage response (DDR) or after 48 hr of DNA damage recovery (Fig-
ure 1a). Following 4‐hr exposure to H2O2, we did not observe lamin
A/C modulation, neither in control nor in HGPS cells (Supporting
TABLE 1 List of human dermal fibroblast cultures used in this study
Fibroblasts culture LMNA mutation Age of donor at biopsy Gender Passage number Used for
CONTROL 1 None 15 F 18–22 MA,WB, IF, PLA
CONTROL 2 None 65 M 14–18 MA, IF, PLA
APS (atypical progeria syndrome) P4R 17 F 14–15 WB, PLA
MADA (Mandibuloacral dysplasia A type) R527H 50 M 13–14 WB, PLA
HGPS (Hutchinson–Gilford progeria syndrome)1 G608G 6 M 20–24 MA, WB, IF, PLA
HGPS (Hutchinson–Gilford progeria syndrome)2 G608G 3 F 12–14 MA
EDMD2 (Emery‐Dreifuss muscular dystrophy) Y259D 11 F 14–16 WB, PLA
Note. IF: immunofluorescence; MA: microarray; PLA: proximity ligation assay; WB: western blot analysis.
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Information Figure S1a,b), while prelamin A was significantly
increased and its levels were decreased after stress recovery (Sup-
porting Information Figure S1a–c), as previously reported (Lattanzi
et al., 2014). Of note, also progerin, the truncated prelamin A form
accumulated in HGPS cells tended to increase during DDR (Support-
ing Information Figure S1a–d). In this context, we evaluated the
expression pattern of CDKN1A, whose modulation during DDR is a
key event to avoid shift into a senescence program (Cazzalini et al.,
2010). Modulation of CDKN1A levels was observed in control samples
subjected to oxidative stress, where CDKN1A transcripts were signifi-
cantly increased after 4‐hr H2O2 treatment and returned to basal
level upon stress recovery (Figure 1b). However, in HGPS cells,
CDKN1A was upregulated under basal conditions with respect to con-
trol cells, while its relative increase upon oxidative stress was lower
F IGURE 1 Altered p21 modulation during stress response in HGPS cells. Control or HGPS fibroblasts were left untreated (NT), exposed to
H2O2 for 4 hr (H2O2), or harvested after 48 hr of H2O2 recovery (recovery). (a) Sketch of the oxidative stress experiment aligned along the time
axis. (b) Quantitative RT‐PCR of CDKN1A expression. (c) (i) Western blot of p53, phospho‐p53 (p53–S15), and p21; (ii) densitometry of p21
bands, (iii) densitometry of p53 bands, and (iv) densitometry of p53–S15 bands; (d) (i) SA‐βGal staining of control and HGPS cells left untreated
or after H2O2 recovery; (ii) quantitative analysis of SA‐βGal‐positive cells. (e) SA‐βGal and DAPI co‐staining in normal and HGPS cells showing
SAHF (arrowheads). (f) (i) DAPI staining of nuclei of normal, APS, MADA, and HGPS fibroblasts; (ii) percentage of cells with SAHF
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than in controls (Figure 1b) and high transcript levels persisted after
oxidative stress recovery (Figure 1b). Modulation of p21 protein level
followed the same pattern (Figure 1c). These results suggested dereg-
ulation of CDKN1A expression. However, as proteasome‐mediated
degradation of p21 is known to contribute to modulation of protein
levels during DDR (Cazzalini et al., 2010), we wanted to test the pos-
sibility that proteasomal degradation of p21 could be impaired in
HGPS. The same extent of proteasome‐mediated proteolysis was
observed during stress recovery in control and HGPS cells, as deter-
mined by measuring protein accumulation upon MG132 treatment
(Supporting Information Figure S2a). On the other hand, we did not
observe any autophagic degradation of p21 during oxidative stress
recovery neither in controls nor in HGPS cells, as determined by
chloroquine treatment (Supporting Information Figure S2b). We con-
cluded that p21 accumulation in HGPS cells during recovery from
oxidative stress was mainly due to increase in CDKN1A transcripts.
This could also involve a p53‐dependent mechanism, as p53 is a
major player in stress response and regulator of p21 expression.
However, by analyzing the stress‐response transcriptome, we found
that BRCA1, TGF beta 1, 2, and 3, SMAD1, and interferon beta 1, all
genes affecting p53 activity, were not dysregulated in HGPS cells
(Supporting Information Figure S3). Moreover, while levels of phos-
pho‐p53 (Serine 15, pp53) were elevated under basal conditions in
HGPS fibroblasts, both p53 and pp53 dynamics during stress were
comparable to age‐ and passage‐matched controls (Figure 1c). Thus,
p21 increase in HGPS cells subjected to oxidative stress appeared
also due to a p53‐independent dysregulation of CDKN1A expression.
Importantly, persistence of high p21 levels in HGPS cells was
associated with cellular senescence, as demonstrated by the signifi-
cant increase in the percentage of beta‐galactosidase‐positive cells
observed in HGPS, but not in control cultures, upon stress recovery
(Figure 1d) and by the increase in senescence‐associated heterochro-
matin foci (SAHF) (Aird & Zhang, 2013), which were detectable in
almost all beta‐galactosidase‐positive HGPS cells (Figure 1e). The
onset of a senescent phenotype upon oxidative stress recovery was
also observed in cells from other progeroid laminopathies, including
APS and MADA, where the low percentage of SAHF‐containing
nuclei measured under basal conditions was significantly increased
upon stress recovery (Figure 1f).
2.2 | Regulation of stress response and p21 by
lamin A/C
However, within the small group of genes showing an altered tran-
scriptional response to oxidative stress in HGPS cells (Table 2), the
majority were interconnected in the p53‐p21 pathway (Figure 2a).
In support of a role of lamin A/C in p21 regulation, we were able
to detect lamin A/C binding to CDKN1A promoter (Figure 2b). Speci-
ficity of lamin A/C binding was demonstrated, as an unrelated anti-
body, anti‐NF‐YA, did not bind the same region. As negative control,
we used CXCR4 promoter that is bound neither by lamin A/C nor by
NF‐YA (Figure 2b). Lamin A/C binding was detected in a region span-
ning 1,450 bp upstream the TSS, which includes an HDAC2 binding
site (Figure 2b) (Peng et al., 2015). Consistent with a major involve-
ment of lamin A/C and HDAC2 in p21 regulation, we observed
increase in p21 protein levels in HDAC2‐depleted as well as in lamin
A/C‐depleted control fibroblasts (Figure 2c). Interestingly, increased
lamin A/C binding to CDKN1A promoter was observed in HGPS cells,
but the interaction between the promoter and HDAC2 was signifi-
cantly reduced (Figure 2d). The latter result suggested that loss of
lamin A/C‐HDAC2 interaction in HGPS could affect HDAC2 recruit-
ment to the p21 promoter.
2.3 | Lamin A/C interacts with HDAC2, and binding
is decreased in progeroid cells
Thus, we decided to investigate the interplay between HDAC2
and lamin A/C in control and progeroid cells. Coimmunoprecipita-
tion (IP) experiments showed in vivo binding of lamin A and
HDAC2 (Figure 3a). The interplay was confirmed by in situ prox-
imity ligation assay (PLA) (Cenni et al., 2014) showing that
HDAC2‐lamin A/C complexes were formed in the nucleus of con-
trol skin fibroblasts, and PLA signals were enriched at the nuclear
envelope in 47% of cells (Figure 3b). Signals were not observed in
the absence of lamin A/C antibody (Figure 3c) nor after HDAC2
or lamin A/C knockdown (Figure 3c). Moreover, an unrelated anti-
body (anti‐MEF2C) did not elicit any PLA signal when used in
combination with anti‐lamin A/C (Figure 3c). These experiments
confirmed the specificity of PLA signals. Then, we examined lamin
A/C‐HDAC2 interaction in fibroblasts from progeroid laminopathies.
APS, MADA, or HGPS fibroblasts expressing P4R LMNA, R527H
LMNA, or G608G LMNA, respectively, showed significantly reduced
lamin A/C‐HDAC2 interaction (Figure 3d). However, in cells from
Emery‐Dreifuss muscular dystrophy (EDMD2) expressing Y259D
mutated LMNA, HDAC2‐lamin A/C binding was comparable to con-
trols (Figure 3d). A z‐stack analysis of PLA signal distribution
showed that reduction in lamin A/C‐HDAC2 binding in HGPS
occurred also at the nuclear periphery (Figure 3e). This was not
due to reduced lamin A/C levels, as, in all the examined lamino-
pathic cells, lamin A/C levels were comparable to controls (Sup-
porting Information Figure S4a–c), although prelamin A
accumulation was observed in HGPS and MADA, as previously
determined (Lattanzi, 2011), and unexpectedly in APS cells (Sup-
porting Information Figure S4a,d). Co‐IP experiments confirmed
reduced binding between lamin A/C and HDAC2 in HGPS fibrob-
lasts relative to controls (Figure 3f). However, also progerin coim-
munoprecipitated endogenous HDAC2, though with lower affinity,
(Figure 3g) and was detected in HDAC2‐containing complexes as
determined by PLA (Figure 3h), suggesting that the mutated pro-
tein could compete for wild‐type lamin A interaction with the
enzyme. In fact, overexpression of progerin in control fibroblasts
exerted a dominant negative effect on lamin A/C‐HDAC2 binding
(Figure 3h). Of note, in cells overexpressing progerin and showing
reduced lamin A/C‐HDAC2 interaction, p21 levels were signifi-
cantly increased (Figure 3h), suggesting a correlation between loss
of enzyme binding to lamin A/C and increase in p21 expression.
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2.4 | Lamin A/C activates HDAC2 more strongly
than progerin
Then, we examined lamin A/C and HDAC2 interplay with the HDAC2
substrates H4 histone acetylated on lysine 16 (acH4K16) and H3 his-
tone acetylated on lysine 9 (acH3K9) in control and HGPS cells. As
expected, HDAC2 bound acH4K16 (Figure 4a). However, the
interaction was significantly reduced in HGPS, although acH4K16
levels were increased (Figure 4a). As a control, we used the HDAC2
inhibitor MS275 (Panella et al., 2016) that significantly reduced
HDAC2‐acH4K16 binding, while increasing H4K16 acetylation (Fig-
ure 4a). Importantly, the HDAC2‐lamin A/C‐containing platform also
included HDAC2 substrates. In fact, an interaction of lamin A/C with
acH4K16 (Figure 4b) and acH3K9 (Figure 4c) was observed by PLA. In
TABLE 2 Genes differently regulated upon stress in HGPS cells. Changes in gene expression in control and HGPS cells subjected to 4‐hr
H2O2 treatment are reported. A ratio >1.8 or a ratio <0.55 in control or HGPS was used in the study
Gene
symbol
Change in control
upon stress
Change in HGPS
upon stress Gene designation Annotated functions **S ***L
FOSB 76,1 *163,8 AP−1 transcription factor
subunit
Involved in cell proliferation and
differentiation
X
GADD45A 10,3 *17,3 Growth arrest and DNA
damage‐inducible alpha
Involved in stress response X
GDF15 6,6 *17,0 Growth differentiation factor 15 Involved in stress response X
SPSB1 2,1 *6,3 SplA/ryanodine receptor domain Probable substrate recognition component
of a SCF‐like ECS
RRAD 2,8 *5,9 Ras‐related glycolysis inhibitor Interacts with CAMK2G and TPM2 X
SERTAD1 2,5 *5,6 SERTA domain containing 1 Interacts with p16, CREB‐binding protein,
and CDK4
TBX3 3,5 *5,3 T‐box3 Regulator of developmental processes
PPP1R10 1,4 *5,1 Protein phosphatase 1
regulatory subunit 10
Involved in cell cycle progression, DNA
repair, and apoptosis
CBX4 1,7 *5,1 Chromobox homolog 4 Epigenetic regulation of cell proliferation
and differentiation
X
MIR320A 1,3 *4,3 MicroRNA320a Regulator of gene expression
CEBPG 2,0 *3,8 CCAAT/enhancer binding
protein gamma
Regulator of viral and cellular transcription X
CEBPA 1,1 *3,6 CCAAT/enhancer binding
protein alpha
Involved in cell cycle progression X
MMP25 1,9 *3,2 Matrix metallopeptidase 25 Involved in the breakdown of extracellular
matrix
NR4A2 2,3 *3,0 Nuclear receptor subfamily 4
group A member 2
Regulator of gene expression X
KLF6 1,4 *3,0 Kruppel‐like factor 6 Involved in the tumor suppression X
LDHC 1,54 *2,9 Lactate dehydrogenase C Enzyme involved in anaerobic glycolysis
OTUD1 1,1 *2,8 OTU deubiquitinase 1 Deubiquitinating enzymes
DUSP16 1,5 *2,4 Dual specificity phosphatase 16 Gene expression, cell proliferation,
differentiation, and apoptosis
CSRNP2 1,7 *2,4 Cysteine and serine‐rich nuclear
protein 2
Regulator of gene expression
RND1 1,1 *2,1 Rho family GTPase 1 Involved in the organization of the actin
cytoskeleton
CDKN1A *4,7 2,0 Cyclin‐dependent kinase
inhibitor 1
Cell cycle progression, DNA replication, and
DNA damage repair
X X
DIP2A 0,7 *0,5 Disco‐interacting protein 2
homolog A
Involved in axon patterning in the central
nervous system
ASTE1 0,8 *0,5 Asteroid homolog 1 Regulator of gene expression
AAK1 0,6 *0,4 AP2‐associated kinase 1 Involved in endocytosis process
*Statistically significant difference relative to corresponding untreated samples, p < 0.01.
**S, stress involvement.
cCDKN1A gene is the only gene in the list involved in both stress and lamin A‐related mechanisms.
***L, lamin interplay.
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HGPS fibroblasts, we observed a significant reduction in lamin A/C
binding to acetylated H4K16 (Figure 4b) and H3K9 (Figure 4c), while
acetylated histone levels were increased (Figure 4b,c). As a negative
control, PLA of lamin A/C and trimethylated H4K20 histone was per-
formed (Supporting Information Figure S5).
In support of the hypothesis that lamin A/C could affect HDAC2
activity, we were able to determine an interaction between lamin A/C
and the phosphorylated form of HDAC2 (serine 394, pHDAC2), which
was enriched at the nuclear periphery in 33% of examined nuclei (Fig-
ure 4d). Lamin A/C interaction with pHDAC2 was significantly
F IGURE 2 Regulation of stress response and p21 by lamin A/C. (a) String map (https://string-db.org/) indicating interconnections among
genes analyzed in the microarray reported in Table 2. Genes upregulated in HGPS after H2O2 treatment with respect to H2O2‐treated human
normal fibroblasts are indicated by an arrow, and genes whose regulation after H2O2 treatment is hampered in HGPS are indicated by the
symbol┤. (b) (i) Chromatin immunoprecipitation (ChIP) of lamin A/C on the CDKN1A promoter in normal fibroblasts. The promoter of CDKN1A
and CXCR4 (unrelated promoter) was detected by qPCR with specific primers listed in Experimental procedures. Protein binding is expressed as
the percentage of the total DNA input. CDKN1A promoter regions bound by lamin A/C (R1, R2, R3, R4) are indicated; (ii) Schematic
representation of regions bound by lamin A/C (R1, R2, R3, R4), on CDKN1A gene promoter. (c) (i) Western blot of p21, lamin A/C and HDAC2 in
fibroblasts left untreated or after siRNA silencing of HDAC2 or Lamin A/C and (ii) corresponding densitometry. (d) ChIP of (i) lamin A/C or (ii)
HDAC2 on the CDKN1A promoter in normal or HGPS fibroblasts. CDKN1A promoter region (R4) bound by lamin A/C or HDAC2 is indicated
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reduced in HGPS with respect to control cells (Figure 4d), although
mean pHDAC2 fluorescence intensity and the fluorescence intensity
profile were not affected (Figure 4d). On the contrary, lamin A/C stain-
ing was accumulated at the nuclear periphery in HGPS, while both
peripheral and nucleoplasmic localization of lamin A/C was detected in
control nuclei (Figure 4d). However, although progerin binding to
pHDAC2 was also detected (Figure 4e), suggesting that progerin could
compete with lamin A/C for the interaction with the active enzyme,
HDAC2 phosphorylation did not influence binding affinity between
the lamin A/C and HDAC2 (Figure 4f). In fact, phosphomimetic or non-
phosphorylable forms of HDAC2 were equally recovered in lamin A/
C‐containing immunocomplexes (Figure 4f). Importantly, data
obtained in an experimental model, HEK293 cells overexpressing
LMNA mutants, suggested that wild‐type lamin A promotes HDAC2
activity toward both acH4K16 and acH3K9, while progerin fails to
properly regulate histone acetylation (Figure 4g).
2.5 | Lamin A/C‐dependent oxidative stress
response and recovery is impaired in HGPS
Then, we set out to investigate the fate of lamin A/C‐HDAC2 com-
plexes during oxidative stress‐induced DDR. In control fibroblasts,
lamin A/C‐HDAC2 interaction was reduced 4 hr after oxidative stress
induction, when 53 binding protein 1 (53BP1) foci indicated DNA
damage, and basal levels were restored in cells that had resolved DNA
damage sites (Figure 5a). Conversely, in HGPS cells, the low number
of lamin A/C‐HDAC2 PLA signals observed under basal conditions
was further reduced during DDR and even upon stress recovery (Fig-
ure 5a). However, HDAC2 levels and fluorescence intensity profile
were not significantly affected during DDR neither in control nor in
HGPS (Figure 5b‐c) although higher amount of HDAC2 was measured
in HGPS cells (Figure 5c and S6). Parallel modulation of HDAC2 bind-
ing to its substrate acH4K16 was observed during oxidative stress
response in control fibroblasts but not in HGPS (Figure 5d). Moreover,
acetylation of H3K9 and H4K16 was increased in control fibroblasts
4 hr after oxidative stress stimulus and basal levels were restored at
recovery, an acetylation pattern disrupted in HGPS cells (Figure 5e–f).
These results demonstrated that defects in modulation of lamin A/C‐
HDAC2 interaction alter heterochromatic H3K9 and H4K16 histone
acetylation pattern and oxidative stress recovery in HGPS cells.
3 | DISCUSSION
The main achievement of this study is the characterization of a func-
tional interplay between lamin A/C and HDAC2 in human fibroblasts,
which is modulated during DDR and contributes to regulation of
HDAC2 activity and p21 expression. Importantly, we show that the
protein platform, which, also includes HDAC2 substrates acetylated
H3K9 and H4K16, is disrupted in HGPS, where CDKN1A downregu-
lation upon stress recovery is affected leading to cellular senescence.
The observation that p21 modulation during oxidative stress
response is altered in HGPS cells, both at the mRNA and protein
level, suggested that functional lamin A/C was required for CDKN1A
regulation. Our data show that in fact lamin A/C binds the CDKN1A
promoter and the interaction between lamin A/C and HDAC2 favors
HDAC2 recruitment (Noh et al., 2011), as suggested by reduced
deacetylase binding in HGPS, despite increased protein levels.
Data showing that coexpression of lamin A/C and HDAC2 favors
histone deacetylation, strongly suggested that lamin A/C contributes
to HDAC2 activation. In support of this, we observed that deacetyla-
tion of H4K16 and H3K9 is hampered in HGPS cells and unraveled a
dominant negative effect of progerin on lamin A/C‐dependent upregu-
lation of HDAC2 activity. This dominant negative effect is associated
with reduced lamin A/C‐HDAC2 interaction in cells expressing pro-
gerin, as determined both in experimental models and HGPS fibrob-
lasts. Besides HGPS, we demonstrate a reduced interaction between
lamin A/C and HDAC2 in other progeroid laminopathies. The fact that
lamin A/C levels are the same in control and in progeroid cells is critical
to concluding that mutated lamins disrupt stress response by compet-
ing with lamin A/C for HDAC2 interaction. Nevertheless, impaired
HDAC2 recruitment to the lamin A/C‐containing platform occurs irre-
spective of the mutated LMNA sequence, a finding that suggests
involvement of other molecular defects common to progeroid lamino-
pathies, such as prelamin A accumulation (Cenni et al., 2018). How-
ever, the enhanced severity of HGPS cellular phenotype (Camozzi
et al., 2014) correlated with the lower level of HDAC2‐lamin A/C inter-
action in HGPS with respect to other progeroid cells.
As a whole, here we characterize HGPS cells at recovery from
oxidative stress, by showing that in that context lamin A/C‐HDAC2
interaction is severely affected, p21 levels are increased, and cells
accumulate SAHF and senescence markers. In fact, defective modu-
lation of p21 expression and formation of SAHF and p16 increase
may account for the high number of cells that enter senescence at
recovery from stress. We suggest that senescent cells accumulate in
HGPS after several stress events due to failure to restore p21 levels
and properly reorganize heterochromatin. It has been reported that
organism senescence is related to the number of senescent cells,
especially in stem cell niches (Bhatia‐Dey, Kanherkar, Stair, Makarev,
& Csoka, 2016). Thus, altered HDAC2 functionality may directly con-
tribute to the accelerated aging process in laminopathic patients.
As HDAC3 has been shown to bind the nuclear envelope protein
emerin in muscle progenitors (Demmerle et al., 2013) and HDAC1‐3
have been shown to bind emerin and BAF in neuroblastoma cells (Tsai
et al., 2015), we cannot rule out the possibility that tissue‐specific
interactions of nuclear envelope proteins with diverse epigenetic
enzymes might occur (Batrakou, Las Heras, Czapiewski, Mouras, &
Schirmer, 2015; Worman & Schirmer, 2015). Along this line, mutations
causing EDMD2 do not impair lamin A/C‐HDAC2 interaction (this
study), while defects in emerin‐HDAC3 binding have been reported in
EDMD1 (Collins, Ellis, & Holaska, 2017). Moreover, we cannot rule
out that the interaction between HDAC2 and lamin A/C could be
mediated by nuclear envelope proteins, other components of the pro-
tein platform or even chromatin, an issue to be further explored.
Having determined an altered interplay of lamin A/C with
HDAC2 in HGPS may open new therapeutic perspectives based on
the use of drugs able to restore this interplay. A number of
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epigenetic drugs, including TSA (Columbaro et al., 2005), MS275,
and other small molecules targeting class I histone deacetylases, war-
rant further investigation.
Data here reported are also relevant to normal aging. Our group
and others demonstrated modulation of prelamin A levels during
physiological aging and particularly in response to stress stimuli (Lat-
tanzi et al., 2014; Liu et al., 2013). It appears conceivable that prela-
min A‐dependent effects on HDAC2‐lamin A/C interaction, currently
under investigation, might be relevant to organism aging under phys-
iological conditions.
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It will be also interesting to determine the effect of lamin A/C‐
HDAC2 interplay on other targets of HDAC2, such as regulatory
microRNAs (Tian et al., 2014), nonhistone proteins, transcription fac-
tors, and enzymes, whose stability and/or activity are modulated
through regulation of their acetylation levels. This will increase our
knowledge of the role of lamin A/C‐containing platforms in human
aging and diseases.
4 | EXPERIMENTAL PROCEDURES
4.1 | Cell culture and transfection
Fibroblast cultures were obtained from skin biopsies of healthy
patients undergoing orthopedic surgery or laminopathic patients, fol-
lowing written consent. The protocol had been approved by the local
ethical committee and followed EU rules. Cell cultures were estab-
lished and cultured in Dulbecco's modified Eagle's medium, supple-
mented with 20% fetal bovine serum (Gibco) and antibiotic solution.
HEK293 were cultured in D‐MEM plus 10% fetal bovine serum. Skin
fibroblasts expressing P4R LMNA from atypical progeria syndrome
(APS) (Garg et al., 2009), R527H LMNA from mandibuloacral dys-
plasia (MADA) (Novelli et al., 2002), G608G LMNA from HGPS (De
Sandre Giovannoli et al., 2003; Eriksson et al., 2003; Pellegrini et al.,
2015), and cells from Emery‐Dreifuss muscular dystrophy (EDMD2)
expressing Y259D mutated LMNA (Mattioli et al., 2011) or control
fibroblasts were included in this study (Table 1).
4.2 | Plasmids and siRNA
Plasmids used for transfections: GFP‐lamin A, FLAG‐lamin A, FLAG‐
progerin or wild‐type FLAG‐HDAC2, nonphosphorylable FLAG‐
HDAC2 S394A, and phosphomimetic FLAG‐HDAC2 S394D (Peng
et al., 2015). Transfection of HEK293 cells was performed using
FuGENE 6 (Promega) according to the manufacturer's instructions,
and cells were incubated for 24 hr after transfection. Transfection of
human fibroblasts was performed using AMAXA Nucleofector (Lon-
za), according to the manufacturer's instructions. After transfection,
fibroblasts were incubated for 48 hr. Expression of HDAC2 or lamin
A/C was silenced in human fibroblasts with predesigned siRNA:
HDAC2 siRNA (SC‐29345, Santa Cruz) and lamin A/C siRNA (SC‐
3577 Santa Cruz) according to the manufacturer's instructions.
50 pmols of siRNA were used for transfections. HDAC2 silencing
was performed for 7 days, and lamin A/C silencing was performed
for 12 days. Validation was performed by western blot.
4.3 | Microarray hybridization, processing, and data
analysis
Gene expression profile was evaluated using HumanHT‐12 v3 Bead-
Chips whole‐genome hybridization assay (Illumina), which is based
upon fluorescence detection of biotin‐labeled cRNA. Each array con-
tains full‐length 50‐mer probes representing >48,000 well‐annotated
RefSeq transcripts, including >25,400 unique, curated, and up‐to‐
date genes derived from the National Centre for Biotechnology
Information Reference Sequence database (NCBI). Initially, 300 ng of
total RNA was converted to cDNA, followed by an in vitro transcrip-
tion step to generate Biotin‐16‐UTP‐labeled cRNA using the Ambion
Illumina Total Prep RNA Amplification Kit (Ambion). The labeled
probes were mixed with hybridization reagents and hybridized over-
night to the HumanHT‐12 v3 BeadChips (Illumina). Following wash-
ing and staining, the BeadChips were imaged using the Illumina
BeadArray Reader (Illumina) to measure fluorescence intensity for
each probe. The intensity of the signal corresponds to the quantity
of the respective mRNA in the original sample. Raw data were
extracted using GenomeStudio software (Illumina); then, all samples
were normalized by quantile normalization procedure. Statistical
comparisons were performed by Student's t test: To define a statisti-
cally significant variation in expression level, we considered a
F IGURE 3 Lamin A/C interacts with HDAC2 in human normal fibroblasts more strongly than progeroid mutants. (a) Co‐IP of GFP‐lamin A
and FLAG‐HDAC2 (IP FLAG) in HEK293 cells. IP control IgG, negative control. Molecular weight markers are indicated. (b) (i)
Immunofluorescence staining of lamin A/C and HDAC2 and PLA of lamin A/C and HDAC2 (PLA) in human normal fibroblasts. PLA of lamin A/
C and HDAC2 and lamin A/C staining are merged in the right picture (merge); (ii) percentage of nuclei showing less than 50% of signals at the
periphery (PLA lamin A/C‐HDAC2 homogenous distribution) or more than 50% of signals at the periphery (PLA lamin A/C‐HDAC2 enrichment
at the periphery); (iii) fluorescence intensity profile of lamin A/C and HDAC2 in a representative nucleus. (c) (i) PLA of lamin A/C and HDAC2
in the presence (left picture) or absence of lamin A/C antibody (no anti‐lamin A/C antibody) and (ii) quantitative analysis; (iii) PLA of lamin A/C
and HDAC2 after HDAC2 knockdown (HDAC2 siRNA); (iv) PLA of lamin A/C and HDAC2 after lamin A/C knockdown (lamin A/C siRNA) and
(v) quantitative analysis of PLA signals in the indicated samples; (vi) lamin A/C and MEF2c staining and PLA of lamin A/C and MEF2c (no
signals were detected). (d) (i) PLA of lamin A/C and HDAC2 in fibroblasts from healthy subjects, HGPS, APS, MADA, or EDMD2 patients (see
Table 1 for details) and (ii) quantitative analysis of PLA. (e) (i) Selected focal planes from the z‐stack of nuclei from normal or HGPS cells
subjected to lamin A/C‐HDAC2 PLA. PLA signals are red dots, IF staining of lamin A/C is shown in green; (ii) number of PLA signals at the
nuclear periphery reported as percentage of total PLA signals. (f) (i) Co‐IP of lamin A/C and HDAC2 in normal or HGPS fibroblasts (IP lamin A/
C) and (ii) densitometric analysis of immunoprecipitated HDAC2. (g) (i) Co‐IP of FLAG‐lamin A or FLAG‐progerin and endogenous HDAC2 in
HEK293 cells. IP control IgG, negative control; (ii) quantitative analysis of immunoprecipitated HDAC2, values were normalized to
immunoprecipitated LMNA products. (h) (i) PLA of progerin and HDAC2 in HGPS cells and quantitative analysis of PLA signals. (ii) PLA of lamin
A/C and HDAC2 in control fibroblasts transfected with WT FLAG‐lamin A or FLAG‐progerin. FLAG staining (green) is merged with DAPI. p21
co‐staining is shown on the right (p21).Representative nuclei out of 100 examined nuclei are shown; (iii) quantitative analysis of PLA signals in
transfected cells performed in nuclei showing the same fluorescence intensity values for FLAG; (iv) p21 mean fluorescence intensity in
transfected cells. Nuclei in c, d, e, h were counterstained with DAPI
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combined threshold based on p‐value (p < 0.01) and ratio between
average gene expression values (R > 1.8 or R < 0.55).
4.4 | Antibodies and drugs
Antibodies used in this study are listed in Table 3. Anti‐lamin A/C
and anti‐prelamin A antibodies used in this study have been previ-
ously characterized in control and HGPS cells (Cenni et al., 2014;
Columbaro et al., 2005; Lattanzi et al., 2014). The class I HDAC inhi-
bitor MS‐275 (entinostat) was applied 5 µM for 18 hr to fibroblasts
cultures. To induce oxidative stress, 100 µM hydrogen peroxide
(H2O2) was added to human fibroblasts cultures for 4 hr. Recovery
was measured 48 hr after H2O2 removal. After 24 hr of H2O2
removal, 40 µM MG132 (Sigma) was applied for 4 hr to fibroblasts
cultures, whereas 1 µM chloroquine (Sigma) was applied for 20 hr.
4.5 | In situ PLA
In situ PLA was performed using kits from Sigma‐Aldrich: Duolink® In
Situ Detection Reagents Orange (DUO92007) according to the manu-
facturer. Briefly, methanol‐fixed samples were incubated with 4% BSA
in PBS to saturate nonspecific binding and subsequently with primary
antibodies overnight at 4°C. Thereafter, slides were incubated for 1 hr
at 37°C with secondary probes diluted to final concentrations of 1:5.
Ligation solution was added for 30 min at 37°C. Ligation solution was
removed with wash buffer A, and amplification solution was added for
100 min at 37°C and removed with wash buffer B. Duolink in situ
mounting medium with DAPI was added, and samples were observed
by a Nikon Eclipse Ni fluorescence microscope equipped with a digital
CCD camera and NIS‐Elements AR 4.3 software. Quantitative analysis
of PLA results was performed using Duolink Image Tool software
(Sigma) by counting 300 nuclei per sample.
4.6 | Immunofluorescence analysis
Cells grown on coverslips were fixed with absolute methanol at
−20°C for 7 min. After saturation with 4% BSA in PBS, coverslips
were incubated with primary antibodies overnight at 4°C and with
secondary antibodies for 1 hr at RT. Samples mounted with antifade
reagent were observed with a Nikon Eclipse Ni epifluorescence
microscope. Images captured with NIS‐Elements 4.3 AR software
were elaborated using Photoshop CS.
4.7 | Immunoblot and IP
For western blot analysis, human fibroblasts were lysed in a buffer
containing: 20 mM Tris‐HCl (pH = 7.5), 1% SDS, 1 mM Na3VO4,
1 mM PMSF, 5% beta‐mercaptoethanol, and protease inhibitors.
After sonication (ultrasonic frequency 30 kHz), centrifugation, and
protein quantification by Bradford method, proteins were subjected
to SDS gradient gel (5%–20%) electrophoresis and transferred to
nitrocellulose membrane overnight at 4°C. Incubation with primary
and secondary antibodies was performed, and immunoblotted bands
were revealed by Invitrogen ECL detection system. Densitometry
was performed by a Bio‐Rad GS800 Densitometer. Densitometric
values were normalized to corresponding GAPDH bands if not dif-
ferently stated.
For IP, transfected cells were lysed in a high salt and high deter-
gent‐IP buffer containing: 50 mM Tris‐HCl (pH = 8), 300 mM NaCl,
0.1% SDS, 1% NP‐40, 1 mM PMSF, and protease and phosphatase
inhibitors. For each sample, 700 µg of lysate was incubated over-
night with 1 µg of anti‐FLAG or 3 µg of anti‐GFP or nonspecific
immunoglobulins form Santa Cruz as a negative control. After the
addition of 30 μl of protein A/G (Santa Cruz) for 60 min at 4°C, the
immunoprecipitated proteins were washed 3 times in IP buffer.
Later, the samples were added to Laemmli's buffer, boiled, and sub-
jected to western blot analysis.
IP experiments were also performed to detect endogenous pro-
tein in human dermal fibroblasts. To obtain an enriched nuclear
fraction, cell pellet was resuspended in a buffer containing 10 mM
Tris‐HCl pH 7.8 and protease inhibitors for 10 min on ice to induce
hypotonic shock. Cells were sheared by passages through a 22‐
gauge needle, and nuclei were recovered by 1,000 g centrifugation
at 4°C for 10 min. High detergent‐IP buffer containing 50 mM Tris‐
HCl (pH = 8), 150 mM NaCl, 0.1% SDS, 1% NP‐40, 1 mM PMSF,
and protease and phosphatase inhibitors was added to pellet of
enriched nuclear fraction. This IP buffer has been previously shown
to solubilize hard‐to‐extract nuclear lamina constituents. Then, about
F IGURE 4 Lamin A/C complexes with acetylated HDAC2 substrates and influences HDAC2 activity. (a) (i) Human normal (control) or HGPS
fibroblasts (HGPS) subjected to IF for H4K16ac and HDAC2 and PLA for HDAC2‐H4K16ac interaction. Cells treated with MS275 (MS275)
were used as controls; (ii) quantitative analysis of PLA signals; (iii) western blot analysis of H4K16ac in control and HGPS cells or in control
cells treated with MS275; (iv) mean densitometric values of immunoblotted H4K16ac bands. (b) (i) IF analysis of H4K16ac and lamin A/C and
PLA for H4K16ac‐lamin A/C interaction in normal and HGPS cells and (ii) quantitative analysis of PLA signals. (c) (i) IF analysis of H3K9ac and
lamin A/C and PLA for lamin A/C‐H3K9ac interaction and (ii) quantitative analysis of PLA signals. (d) (i) IF analysis of lamin A/C and pHDAC2
and PLA for lamin A/C‐pHDAC2 interaction in normal and HGPS cells; (ii) quantitative analysis of PLA signals and (iii) percentage of signals at
the periphery with respect to total signals; (iv) fluorescence intensity profile of lamin A/C and pHDAC2 in representative nuclei of control or
HGPS cells. (e) (i) PLA of progerin and pHDAC2 in HGPS cells; (ii) quantitative analysis of lamin A/C‐pHDAC2 and progerin‐pHDAC2 PLA
signals in HGPS cells. (f) (i) Co‐IP of GFP‐lamin A (IP GFP) and WT FLAG‐HDAC2, S392D FLAG‐HDAC2, or S394A FLAG‐HDAC2 in
transfected HEK293 cells. IP control IgG, negative control; (ii) densitometry of immunoprecipitated protein bands. (g) (i) Western blot analysis
of H4K16ac and H3K9ac in non-transfected HEK293 cells or cells overexpressing HDAC2, lamin A/HDAC2, or progerin/HDAC2 as reported
in the legend; (ii) densitometry of H3K9ac and (iii) H4K16ac immunoblotted bands normalized to H3 values. Nuclei in a, b, c, d, e were
counterstained with DAPI
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350 µg of protein nuclear extracts was immunoprecipitated with
4 µg of anti‐lamin A/C antibody overnight at 4°C. Control IPs were
performed in the presence of nonspecific immunoglobulins. After
addition of 30 µl of Protein A/G, lysates were incubated at 4°C for
1 hr and samples were washed 3 times in IP buffer. Immunoprecipi-
tated protein complexes were added to Laemmli's buffer, boiled, and
subjected to western blot analysis.
4.8 | Quantitative RT‐PCR
Total RNA was extracted using the TRI Reagent Solution (Ambion) and
treated with TURBO DNase (Ambion). cDNAs were prepared by
reverse transcription using the High‐Capacity RNA‐to‐cDNA Kit
(Applied Biosystems) according to the manufacture's protocol. Gene
expression was quantified by qPCR using Fast SYBR Green PCR
Master Mix (Applied Biosystems) and analyzed by StepOnePlus Real‐
Time PCR System (Applied Biosystems). The following primers
were used: GAPDH, 5′‐TCGGAGTCAACGGATTTGGT‐3′ (forward)
and 5′‐TTGCCATGGGTGGAATCATA‐3′ (reverse); CDKN1a 5′‐GCA
GACCAGCATGACAGATTT‐3′ (forward) and 5′‐GGATTAGGG
CTTCCTCTTGGA‐3′ (reverse). CDKN1a transcript level was normal-
ized to those of the internal standard gene GAPDH. The ΔΔCt method
was used to measure the fold change of expression levels. Dissocia-
tion curve analysis was performed to confirm that the fluorescence
was derived from specific amplification.
4.9 | Chromatin IP
1% formaldehyde was added directly to SW‐480 cells, and cells were
incubated at 22°C for 10 min. The reaction was stopped adding
F IGURE 5 Altered modulation of lamin A/C‐HDAC2 interaction during DDR in HGPS cells. Normal (control) or HGPS fibroblasts (HGPS)
were left untreated (NT), exposed to H2O2 for 4 hr (H2O2), or harvested after 48 hr of H2O2 recovery (recovery). (a) (i) PLA of lamin A/C
and HDAC2 in normal human fibroblasts and (ii) quantitative analysis of PLA signals; (iii) PLA of lamin A/C and HDAC2 in HGPS cells and (iv)
quantitative analysis. 53BP1 foci in (i) and (iii) are markers of DNA damage. (b) (i) IF of HDAC2 (HDAC2) in control and HGPS cells during
DDR; (ii) fluorescence intensity profile of HDAC2 during DDR measured in a representative control or (iii) HGPS nucleus. (c) (i) Western blot
analysis of HDAC2 in control and HGPS cells during DDR; (ii) densitometry of immunoblotted HDAC2 bands. (d) (i) PLA of HDAC2 and
H4K16ac in normal and HGPS cells during DDR and (ii) quantitative analysis of PLA signals. Nuclei are counterstained with DAPI. (e) (i)
H3K9ac IF staining and (ii) quantitative analysis of mean fluorescence intensity during DDR in normal or HGPS cells. (f) (i) H4K16ac IF staining
and (ii) quantitative analysis of mean fluorescence intensity during DDR in normal or HGPS cells
TABLE 3 List of antibodies used in this study
ANTIBODY Code Species IF dilution WB dilution PLA dilution ChIP IP
anti‐lamin A/C Santa Cruz, SC‐6215
(N‐terminus)
Goat polyclonal 1:100 1:100 1:100 4 µg
anti‐lamin A/C Novocastra (C‐terminus) Mouse monoclonal 4 µg
anti‐prelamin A Santa Cruz SC‐6214
(amino acids 644‐664)
Goat polyclonal 1:100
anti‐HDAC2 Abcam, AB227149 Rabbit polyclonal 1:200 1:2000 1:200 5 µg
anti‐HDAC2 Santa Cruz, SC‐55541 Mouse monoclonal 1:200 1:200
anti‐phopsho‐HDAC2 S394 Abcam, AB75602 Rabbit polyclonal 1:50 1:50
antiprogerin Enzo 13A4 Mouse monoclonal 1:50 1:100 1:10
anti‐p16ink4 Santa Cruz sc‐468 Rabbit polyclonal 1:100
anti‐H4K16 acetylated Abcam, ab109463 Rabbit polyclonal 1:200 1:4,000 1:200
ant‐H4K20 acetylated Upstate 07463 Rabbit polyclonal 1:200 1:200
anti‐H3K9 acetylated Millipore, 06942 Rabbit polyclonal 1:200 1:500 1:200
anti‐H3 Santa Cruz Goat polyclonal 1:500
anti‐p21 Invitrogen, MA5‐14949 Rabbit polyclonal 1:100 1:1,000
anti‐Flag tag Sigma Mouse monoclonal 1:300 1:3,000 1 µg
anti‐GFP tag Santa Cruz Rabbit polyclonal 1:500 3 µg
anti‐GAPDH Millipore Mouse monoclonal 1:10,000
anti−53BP1 Cell signaling 4937S Rabbit polyclonal 1:50
anti‐p53 Santa Cruz sc‐126 Mouse monoclonal 1:500
anti‐p53‐S15 Cell signaling sc‐9284 Rabbit polyclonal 1:500
anti‐NF‐YA Santa Cruz Rabbit polyclonal 4 µg
anti‐MEF2C Cell signaling sc‐9792 Rabbit polyclonal 1:200
Note. ChIP: chromatin immunoprecipitation assay; IF: immunofluorescence; IP: immunoprecipitation: PLA: proximity ligation assay; WB: western blot
analysis.
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0.125 m glycine. Then, cells were rinsed with cold 1× PBS, incubated
with 0.2 × trypsin‐EDTA in 1× PBS, and scraped. Cells were cen-
trifuged, washed in cold 1× PBS plus 0.5 mm PMSF, and resus-
pended in lysis buffer (5 mm piperazine N,N bis zethone sulfonic
acid (pH 8.85) mm KCl, 0.5% Nonidet P‐40). Next, nuclei were soli-
cited in the sonication buffer (0.1% SDS, 10 mm EDTA, 50 mm Tris‐
HCl (pH 8), and 0.5% deoxycholic acid) for 10 min using a microul-
trasonic cell disruptor. The chromatin was sheared to an average size
of 500 base pairs, and IP was performed with protein G‐agarose
(KPL). The chromatin solution was precleared by adding protein G
for 1 hr at 4°C and incubated at 4°C overnight with 4 μg of anti-
body or nonspecific immunoglobulins (IgGs, Santa Cruz) as negative
control. Input was collected from a control sample supernatant (not
immunoprecipitated antibody). Immunoprecipitates were recovered
by incubation for 2 hr at 4°C with protein G‐agarose precleared pre-
viously in IP buffer (1 μg/μl bovine serum albumin, 1 μg/μl salmon
testis DNA, protease inhibitors, and PMSF). Reversal of formalde-
hyde cross‐linking, RNase A, and proteinase K treatments was per-
formed. DNA was phenol‐extracted, ethanol‐precipitated, and
analyzed by PCR. DNA representing 0.005%–0.01% of the total
chromatin sample (input) or 1%–10% of the immunoprecipitated
was amplified using the following pair of primers: CDKN1aR1: for-
ward 5′‐ TCATTGTGAAGCTCAGTACCAC ‐3′; reverse 5′‐ CCTT
GAAGCCCCTCTGCTTT‐3′; CDKN1aR2: forward 5′‐ AGGTGAGTGTA
GGGTGTAGGG‐3′, reverse‐ 5′ TTCCGGGAAGGAGGGAATTG‐ 3′;
CDKN1aR3 forward 5′‐ TGCAGAGAGGTGCATCGTTT ‐3′; reverse‐
5′‐ CACTCTGGCAGGCAAGGATT ‐ 3′, PCR was performed with the
following pair of primers: CDKN1aR4: forward 5′CTCTGTTC
TGTCTGCCTTGCT‐3′, reverse 5′‐TGGTCCTAGCTCTGCCAGTTA‐3′.
CXCR4 promoter (unrelated promoter): forward 5 AGTGGTTT-
GACCTCCCCTTT ‐3′; reverse‐ 5‐ ACTTGCACCTGCCAGTCTTC ‐ 3′.
Antibodies used for ChIP are listed in Table 3 (Athar & Parnaik,
2015). Quantitative PCR (qPCR) was performed using SYBR Green
on an ABI Prism 7,500 apparatus (Applied Biosystems). The percent-
age (Input %) value was calculated as follows: Input % = 100/2 ΔCt
[normalized ChIP]. The “Input %” value represents the enrichment of
NF‐YA and lamin A/C on a specific region of the CDKN1A promoter.
4.10 | SA‐βGal assay
SA‐βGal staining on human fibroblasts was performed using the
Senescence Detection kit (Abnova) according to the manufacturer's
instructions. Cells were then incubated with SA‐βGal solution for
16 hr at 37°C. Results are reported as percentage of counted
cells.
4.11 | Statistical analysis
Graphs in each panel represent mean values from at least three
independent experiments ± standard error for PLA assay and IF or
± standard deviation for WB and PCR. Statistically significant differ-
ences (p < 0.05) are calculated by Student's t test.
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